Wockhardt Ltd. (WOCKPHARMA): Wockhardt Share Price rises 2.19% as stock gains today
- September 17, 2026
- Posted by: Harsh Piplani
- Category: News
Wockhardt Share Price rose 2.19% to Rs 2,065.55 today, lifting the company’s market capitalisation to Rs 33,525.38 crore. The move places Wockhardt Ltd. in focus in today’s healthcare market update, even as the supplied data does not establish a company-specific catalyst.
Wockhardt Share Price rose to Rs 2,065.55 on 17 September 2026, up Rs 44.25 or 2.19% from the previous close of Rs 2,021.3. The company’s market capitalisation stands at Rs 33,525.38 crore, which makes this a notable same-day price rise in the current market session. Wockhardt Ltd. is trading in a way that naturally draws attention to Wockhardt Share Price Today, but the supplied data does not establish a company-specific catalyst for the move.
The stock opened at Rs 2,025, touched a day low of Rs 2,023 and a day high of Rs 2,068.3. Turnover stood at Rs 3.38 crore. On a factual basis, that keeps Wockhardt Stock News focused on today’s price action, the valuation backdrop and how the company compares with healthcare peers. Univest is tracking the move alongside key financial ratios, sector benchmarks and peer numbers so readers can place the day’s share price rise in context.
Wockhardt Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,065.55 |
| Previous Close | Rs 2,021.3 |
| Today's Move | Rs 44.25 (+2.19%) |
| Open | Rs 2,025 |
| High | Rs 2,068.3 |
| Low | Rs 2,023 |
| Turnover | Rs 3.38 crore |
| Market Capitalisation | Rs 33,525.38 crore |
| Market Cap Category | Large Cap |
Wockhardt Ltd. (WOCKPHARMA) rose to Rs 2,065.55 from the previous close of Rs 2,021.3, a move of Rs 44.25 or 2.19%. The stock opened at Rs 2,025, reached a high of Rs 2,068.3, recorded a low of Rs 2,023.
Wockhardt Share Price Today reflected a session gain of Rs 44.25, or 2.19%, with the stock moving between Rs 2,023 and Rs 2,068.3. The current price of Rs 2,065.55 is close to the day high and well above the previous close of Rs 2,021.3. In plain terms, the available numbers show a firm intraday advance, not a narrative explanation for why it happened.
For readers scanning Wockhardt Share Price updates, the useful facts are simple: the stock rose today, the move was measured rather than extreme, and turnover was Rs 3.38 crore. That combination is enough to make the share price rise relevant for a closer look at fundamentals, sector valuation and peer positioning in Wockhardt Stock News.
Wockhardt Ltd. (WOCKPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 33,525.38 crore |
| P/E Ratio | 80.3x |
| P/B Ratio | 6.52x |
| ROE | 4.29% |
| ROCE | 6.79% |
| EPS | Rs 25.17 |
| Book Value Per Share | Rs 309.81 |
| Dividend Yield | 0% |
Wockhardt Ltd. (WOCKPHARMA) fundamental metrics show P/E 80.3x, P/B 6.52x, ROE 4.29%, ROCE 6.79%. These figures provide context only and are not a buy or sell signal.
Wockhardt Ltd. has a market capitalisation of Rs 33525.38 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 80.3x, P/B at 6.52x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 4.29% and ROCE of 6.79%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 25.17, book value per share of Rs 309.81, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.35x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 80.3x |
| Benchmark Median P/E | 31.35x |
| Benchmark Average P/E | 47.81x |
| Benchmark P/E Range | 3.45x to 661.74x |
| Company P/B Ratio | 6.52x |
| Benchmark Median P/B | 2.98x |
| Company ROE | 4.29% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 6.79% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 33,525.38 crore |
| Benchmark Median Market Cap | Rs 735.67 crore |
Wockhardt Ltd. (WOCKPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Wockhardt Ltd. (WOCKPHARMA) has a P/E ratio of 80.3x, which is above the benchmark median of 31.35x, a difference of +156.14%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Wockhardt Ltd. (WOCKPHARMA) has a ROE of 4.29%, which is below the benchmark median of 11.78%, a difference of -63.58%. Wockhardt Ltd. (WOCKPHARMA) has a ROCE of 6.79%, which is below the benchmark median of 13.65%, a difference of -50.26%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,277.97 | 36.77 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,43,965.63 | 83.5 | 13.83 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,84,478.41 | 84.11 | 20.44 | 26.76 | 19.27 |
| Cipla Ltd. | CIPLA | 1,09,949.53 | 32.59 | 3.12 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,09,625.67 | 24.42 | 4.09 | 19.69 | 21.39 |
Wockhardt Ltd. (WOCKPHARMA) has a P/E ratio of 80.3x compared with the displayed peer median of 36.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 4.29% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 6.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Wockhardt Ltd. (WOCKPHARMA) has a market capitalisation of Rs 33,525.38 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Wockhardt
- Wockhardt Share Price rose 2.19% today to Rs 2,065.55 after closing at Rs 2,021.3.
- The stock’s market capitalisation stands at Rs 33,525.38 crore, which places it well above the industry median in the supplied benchmark set.
- Wockhardt’s P/E ratio is 80.3 and P/B ratio is 6.52, both higher than the industry medians provided.
- ROE of 4.29% and ROCE of 6.79% remain below the same-industry medians and averages in the benchmark data.
- Among the selected healthcare peers, Wockhardt’s valuation sits below Divi’s Laboratories and Torrent Pharmaceuticals on P/E, but above Cipla and Zydus Lifesciences.
About Wockhardt Ltd.
Wockhardt Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data identifies the company through its listed equity, WOCKPHARMA, and places it in a sector that is often assessed through valuation, return ratios, earnings quality and peer comparison. For readers following Wockhardt Share Price and Wockhardt Stock News, that context is important because same-day price movement often looks different when viewed against the company’s business base.
The available information in this article centres on market metrics rather than product-level disclosure. Even so, the company’s presence in a large same-industry benchmark of 200 names shows that it is part of a broad and closely compared pharmaceutical set. That is why Wockhardt Share Price Today is best understood as a blend of market action, valuation and industry positioning rather than as a standalone daily move. Univest presents the numbers in a format that helps readers connect the stock’s price rise with the wider healthcare landscape.
Track Wockhardt Share Price on Univest
Use Wockhardt Ltd. (WOCKPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Wockhardt Share Price on Univest for live share price updates, financial ratios, shareholding pattern, 52-week levels and market insights in one place. The platform also helps users follow Wockhardt Share Price Today alongside fundamental ratios, peer comparison and broader stock analysis. Univest keeps the company’s latest market data organised so investors can review the stock’s price rise, valuation context and sector background without switching between multiple sources.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Wockhardt Share Price rising today?
Ans. The supplied data confirms a 2.19% rise to Rs 2,065.55, but it does not establish a company-specific catalyst. The session move is visible in the price, previous close, open, high, low and turnover numbers.
What is Wockhardt Share Price Today?
Ans. Wockhardt Share Price Today is Rs 2,065.55, compared with the previous close of Rs 2,021.3. The stock gained Rs 44.25 during the session, which makes it a notable same-day mover in the healthcare space.
What is the market capitalisation of Wockhardt Ltd.?
Ans. Wockhardt Ltd. has a market capitalisation of Rs 33,525.38 crore. That places it above the industry median and average in the supplied benchmark set, giving the stock a sizeable presence in healthcare comparisons.
How do Wockhardt valuation ratios compare with peers?
Ans. Wockhardt’s P/E of 80.3 is above Cipla and Zydus Lifesciences but below Divi’s Laboratories and Torrent Pharmaceuticals. Its P/B of 6.52 is also above the broader industry median in the benchmark data.
What do Wockhardt ROE and ROCE show?
Ans. Wockhardt’s ROE is 4.29% and ROCE is 6.79%. Both are below the supplied same-industry median and average, so the return ratios provide a weaker profitability context than many healthcare peers.
What do EPS and book value mean for Wockhardt?
Ans. Wockhardt’s EPS is Rs 25.17 and book value is Rs 309.81. EPS shows earnings attributable to each share, while book value reflects accounting net worth behind each share at the current stage.
Does Wockhardt pay a dividend in the supplied data?
Ans. The supplied dividend yield is 0, so there is no current dividend yield contribution in this dataset. For Wockhardt Share Price analysis, that means valuation and earnings metrics matter more than dividend income here.
